SYNAPAUSE VAGINAL CREAM

Scheduling Status

SYNAPAUSE VAGINAL CREAM is an S2 medicine.

Proprietary Name and Dosage Form

SYNAPAUSE VAGINAL CREAM

What SYNAPAUSE VAGINAL CREAM Contains

Each gram of SYNAPAUSE VAGINAL CREAM contains estriol 1 mg as the active ingredient.

The inactive ingredients include cetyl alcohol, cetyl palmitate, chlorhexidine dihydrochloride, glycerol, lactic acid, octyldodecanol, polysorbate 60, sodium hydroxide, sorbitan stearate and stearyl alcohol.

The preservative is chlorhexidine hydrochloride 0,01 % m/m.

SYNAPAUSE VAGINAL CREAM contains sugar in the form of glycerol, which is a sugar alcohol. It also contains alcohol in the form of glycerol, cetyl alcohol and stearyl alcohol.


What SYNAPAUSE VAGINAL CREAM Is Used For

SYNAPAUSE VAGINAL CREAM is used to help restore the mucosal layer of the vaginal wall.


Before You Apply SYNAPAUSE VAGINAL CREAM

SYNAPAUSE VAGINAL CREAM may not be suitable if any of the following apply:

Do not use SYNAPAUSE VAGINAL CREAM ifDetails
You are pregnant or think you may be pregnantSYNAPAUSE VAGINAL CREAM should not be used during pregnancy
You are breastfeedingSYNAPAUSE VAGINAL CREAM should not be used while breastfeeding
You have a tumourThis includes a breast tumour or tumour in the womb
You have recently had unexpected vaginal bleedingThis should be assessed by a doctor
You have had an allergic reaction to any ingredientThis may include the active or inactive ingredients
You have had abnormal growth of the lining of the wombAlso known as endometrial hyperplasia
You have or have had a blood circulation disorderThis includes blood clots in the veins of the legs or lungs
You have had a blood clotting disorderThis includes thrombophilic disorders such as protein C, protein S or anti-thrombin deficiency
You have or have had a disease caused by blood clots in the arteriesThis includes angina pectoris, stroke or heart attack
You have or have had liver disease and liver function has not returned to normalSYNAPAUSE VAGINAL CREAM may not be suitable
You have porphyriaSYNAPAUSE VAGINAL CREAM may not be suitable

Take Special Care With SYNAPAUSE VAGINAL CREAM

Before starting SYNAPAUSE VAGINAL CREAM, your doctor should ask about your own and your family’s medical history. Your doctor may examine your breasts and/or abdomen and may perform an internal examination.

Periodic check-ups are needed, especially breast examinations. Your doctor will advise how often these should be performed.

After starting SYNAPAUSE VAGINAL CREAM, regular check-ups should take place at least once a year. During these visits, your doctor may discuss the benefits and risks of continuing treatment.

Tell your doctor if you have or have had any of the following conditions, or if they became worse during pregnancy or previous hormone use:

Condition
Uterine fibroids
Endometriosis
Blood clots in the blood vessels, including thrombosis, deep vein thrombosis or lung embolism
Increased risk of developing blood clots
Family history of oestrogen-dependent cancer, such as breast cancer in a close relative
High blood pressure
Heart disease
Liver disorders
Kidney disorders
Diabetes
Gallstones
Migraine or severe headache
Systemic lupus erythematosus
Thickening of the womb layer
Epilepsy
Asthma
Otosclerosis, also known as inherited deafness

Tell your doctor if you notice any change in your condition while using SYNAPAUSE VAGINAL CREAM.


Reasons for Immediately Stopping SYNAPAUSE VAGINAL CREAM

Stop using SYNAPAUSE VAGINAL CREAM and contact your doctor if any of the following occur:

Reason to stopWhat it may indicate
Yellowing of the skinJaundice or reduced liver function
Sudden increase in blood pressurePossible cardiovascular concern
First-time migraine or severe headachesPossible neurological or vascular concern
PregnancySYNAPAUSE VAGINAL CREAM should not be used during pregnancy
BreastfeedingSYNAPAUSE VAGINAL CREAM should not be used while breastfeeding

Effects on Your Risk of Developing Cancer

Endometrial Cancer

Endometrial cancer is cancer of the lining of the womb. Women using hormone replacement therapy, such as SYNAPAUSE VAGINAL CREAM, may have a risk of endometrial cancer.

To help prevent endometrial stimulation, the maximum dose should not be exceeded and should not be used for longer than several weeks. In long-term treatment, your doctor may want to examine the uterus or prescribe a progestogen.

Breakthrough bleeding or spotting may occur during the first few months of treatment.

Contact your doctor if bleeding or spotting:

Bleeding or spotting concern
Continues for more than the first few months
Starts after hormone replacement therapy has been used for some time
Continues after SYNAPAUSE VAGINAL CREAM has been stopped

This may be a sign that the lining of the womb has become thicker.

Breast Cancer

Women who have breast cancer or have had breast cancer in the past should not use SYNAPAUSE VAGINAL CREAM.

Hormone replacement therapy may increase the risk of breast cancer. The risk increases with the duration of hormone replacement therapy use and returns to normal within about five years after stopping treatment.

It is not known whether SYNAPAUSE VAGINAL CREAM carries the same higher risk of breast cancer as other hormone replacement therapies. If concerned, discuss the benefits and risks with your doctor.

Regularly check your breasts for changes, including:

Breast changes to look for
Dimpling of the skin
Changes in the nipple
Lumps that can be seen or felt

Ovarian Cancer

Ovarian cancer is rare but serious. It can be difficult to diagnose because there are often no obvious signs.

Long-term use of oestrogen-only hormone replacement therapy, including treatment for at least five to ten years, is thought to carry a slight risk of ovarian cancer.


Effects on Your Heart or Circulation

Coronary Artery Disease

SYNAPAUSE VAGINAL CREAM is not recommended for women who have heart disease or have recently had heart disease.

If you have ever had heart disease, speak to your doctor before using SYNAPAUSE VAGINAL CREAM.

If symptoms of heart disease occur, such as chest pain spreading to the arm or neck, see a doctor as soon as possible. Do not use more hormone replacement therapy until your doctor says you can.

Stroke

Hormone replacement therapy may increase the risk of stroke.

If symptoms suggestive of stroke occur, such as unexplained migraine-type headaches with or without disturbed vision, see a doctor as soon as possible. Stop using SYNAPAUSE VAGINAL CREAM until your doctor says you can continue.

Blood Clots

Hormone replacement therapy may increase the risk of blood clots in the veins. These clots are also called deep vein thrombosis or DVT. A clot may travel to the lungs and cause chest pain, breathlessness, collapse or death. This is called pulmonary embolism or PE.

DVT and PE are examples of venous thromboembolism or VTE.

You may be more likely to get a blood clot if:

Risk factor
You are older
You are pregnant or have recently had a baby
You have had one or more miscarriages
You use oestrogens such as SYNAPAUSE VAGINAL CREAM
You are seriously overweight
You have had a blood clot before in the leg, lung or another organ
A close family member has had blood clots
You have a blood clotting problem requiring medicine such as warfarin
You are off your feet for a long time due to major surgery, injury or illness
You have systemic lupus erythematosus
You have cancer

If symptoms of a blood clot occur, such as painful swelling in the leg, sudden chest pain or difficulty breathing, see a doctor as soon as possible. Stop using SYNAPAUSE VAGINAL CREAM until your doctor says you can continue.

If surgery is planned, tell your doctor. You may need to stop using SYNAPAUSE VAGINAL CREAM about four to six weeks before the operation to reduce the risk of a blood clot. Your doctor will advise when treatment can be restarted.


Other Effects

Hormone replacement therapy will not prevent memory loss. The risk of memory loss may be somewhat higher in women who start hormone replacement therapy after the age of 65.


Pregnancy and Breastfeeding

If you are pregnant or breastfeeding while using SYNAPAUSE VAGINAL CREAM, consult your doctor, pharmacist or healthcare professional.

Do not use SYNAPAUSE VAGINAL CREAM if you are pregnant or think you may be pregnant.

Do not breastfeed while using SYNAPAUSE VAGINAL CREAM.


Driving and Using Machinery

As far as is known, SYNAPAUSE VAGINAL CREAM has no influence on alertness or concentration.


Important Information About Some of the Ingredients of SYNAPAUSE VAGINAL CREAM

SYNAPAUSE VAGINAL CREAM contains cetyl alcohol and stearyl alcohol. These ingredients may cause local skin reactions such as contact dermatitis.


Taking Other Medicines With SYNAPAUSE VAGINAL CREAM

Always tell your healthcare professional if you are taking any other medicine, including complementary or traditional medicines.

Especially tell your doctor if you take or are to receive:

Medicine or medicine group
Corticosteroid hormones
Oral anticoagulants, which are medicines used to stop blood clots
Succinylcholine, used for muscle relaxation during anaesthesia
Theophyllines, used for asthma
Medicines for epilepsy or sleeplessness
Medicines for fungal, bacterial or viral infections

How to Use SYNAPAUSE VAGINAL CREAM

SYNAPAUSE VAGINAL CREAM should be used as directed by your healthcare professional. Read the instructions on the medicine label. Ask your doctor or pharmacist if you are unsure how to use it.

For vaginal complaints, the usual dosage is one application daily during the first two to three weeks. Later, the dose is gradually decreased, for example to one application twice a week.

Use the applicator to apply the cream into the vagina. It is a good idea to use it before going to bed at night.

One application, with the applicator filled to the ring mark, contains 0,5 g of SYNAPAUSE VAGINAL CREAM, which provides 0,5 mg estriol.


Instructions for Use

  1. Remove the cap from the tube, invert it, and use the sharp point to open the tube.
  2. Screw the end of the applicator onto the tube. Make sure the plunger is fully inserted into the barrel.
  3. Squeeze the tube to fill the applicator with cream until the plunger stops at the red ring.
  4. Unscrew the applicator from the tube and replace the cap on the tube.
  5. To apply the cream, lie down, insert the end of the applicator deep into the vagina and slowly push the plunger all the way in until the applicator is empty.

After use, pull the plunger out of the barrel and wash both parts in warm, soapy water.

Do not use detergents. Rinse well afterwards.

Do not put the applicator in hot or boiling water.

The applicator can be reassembled by fully inserting the plunger into the barrel beyond the point where resistance is felt.

Discard the applicator once the tube is empty.


If You Use More SYNAPAUSE VAGINAL CREAM Than You Should

If some cream has been swallowed, consult a doctor.

Possible symptoms may include:

Possible overdose symptoms
Nausea
Vomiting
Vaginal bleeding in females after a few days

If You Forget to Use SYNAPAUSE VAGINAL CREAM

If you forget to use a dose, use it as soon as you remember, unless you notice the missed dose on the day of your next dose.

If you notice the missed dose on the day of your next dose, do not use the missed dose. Continue with the next dose as normal.

Never use two doses on the same day.


Possible Side Effects

SYNAPAUSE VAGINAL CREAM can have side effects.

Side Effects Table

Side-effect categorySide effects / symptomsRecommended action
General side effectsLocal irritation, itching or excessive cervical mucous productionConsult your doctor if troublesome
General side effectsSwelling and increased tenderness of the breasts, sometimes painfulConsult your doctor if troublesome
Unexpected symptomsUnexpected vaginal bleedingConsult your doctor at once
Other possible side effectsBenign and malignant hormone-dependent tumours such as endometrial cancerSeek medical advice
Other possible side effectsHeart attack and strokeSeek urgent medical attention
Other possible side effectsGall bladder diseaseConsult your doctor
Skin or subcutaneous disordersBrownish pigmentation of the skin, also known as chloasmaConsult your doctor
Skin or subcutaneous disordersSkin diseases with blisters and nodules, or bleeding into the skin, including erythema multiforme, erythema nodosum and vascular purpuraConsult your doctor
Blood clot-related side effectsVenous thromboembolism, including deep leg or pelvic vein blood clots that may pass to the lungsSeek urgent medical attention
Long-term riskUsing SYNAPAUSE VAGINAL CREAM for several years increases the risk of breast cancerDiscuss ongoing treatment and risk with your doctor
Side effects not listedAny unusual, unexpected or untoward effectsConsult your doctor, pharmacist or other healthcare professional

Not all side effects reported for SYNAPAUSE VAGINAL CREAM are included in the patient information. If your general health worsens or you experience unexpected effects while using SYNAPAUSE VAGINAL CREAM, consult your doctor, pharmacist or healthcare professional.


Storage and Disposing of SYNAPAUSE VAGINAL CREAM

Keep the tube of SYNAPAUSE VAGINAL CREAM in the original box in a safe place, out of the reach of children.

Store in a cool place at or below 25 °C.

Do not freeze.


Presentation of SYNAPAUSE VAGINAL CREAM

SYNAPAUSE VAGINAL CREAM is filled in collapsible aluminium tubes containing 15 g of cream.

The tubes are provided with a polyethylene screw cap.

The applicator consists of a polystyrene barrel and a polyethylene plunger.

Each tube is packed together with an applicator in a carton.


Identification of SYNAPAUSE VAGINAL CREAM

SYNAPAUSE VAGINAL CREAM is a white to almost white, smooth, homogenous cream mass.


Registration Number

V/18.6/201


Name, Business Address and Telephone Number of the Holder of the Certificate of Registration

PHARMACARE LIMITED
Healthcare Park
Woodlands Drive
Woodmead 2191


Date of Publication

06 June 2014


Medical Disclaimer

This article is intended as patient information based on the approved leaflet structure. It does not replace advice from a doctor, pharmacist or other healthcare professional. For regulated medical product use, follow the approved patient information leaflet and healthcare professional guidance.

Leave a Comment